Robotic beyond total mesorectal excision (TME) for locally advanced or recurrent rectal cancer: a systematic review protocol.

Journal: BMJ open
Published Date: Jan 25, 2024

Abstract

INTRODUCTION: The surgical treatment for locally advanced or recurrent rectal cancer requires oncological clearance with a pelvic exenteration or a beyond total mesorectal excision (TME). The aim of this systematic review is to explore the safety and feasibility of robotic surgery in locally advanced and recurrent rectal cancer by evaluating perioperative outcomes, oncological clearance rates, and survival and recurrence rates postrobotic beyond TME surgery.

Authors

  • Ioanna Georgiou Panagiotopoulou
    School of Health and Care Professions, Faculty of Science and Health, University of Portsmouth, Portsmouth, UK yianna@doctors.org.uk.
  • Anna Przedlacka
    Department of Colorectal Surgery, Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
  • Guglielmo Niccolo Piozzi
    Division of Colon and Rectal Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
  • Graham A Mills
    School of Health and Care Professions, Faculty of Science and Health, University of Portsmouth, Portsmouth, UK.
  • Mick Harper
    School of Health Sciences and Social Work, University of Portsmouth, Portsmouth, UK.
  • Jim S Khan
    Department of Colorectal Surgery, Portsmouth Hospitals University, NHS Trust, Portsmouth, UK. jim.khan@porthosp.nhs.uk.

Keywords

External Resources

Popular Topics
Recent Journals